Lexaria Bioscience
Quarterly Financials
| Values in thousands | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 |
|---|---|---|---|---|
Revenue | $174 | $174 | $174 | $183 |
Gross Profit | 174 | 174 | 174 | 181 |
EBITDA | -3,719 | -2,748 | -2,657 | |
EBIT | -3,750 | -2,751 | -2,690 | |
Net Income | -2,695 | -3,789 | -2,713 | -2,703 |
Net Change In Cash | 174 | 174 | 174 | 183 |
Free Cash Flow | -2,657 | -3,583 | -1,497 | -2,726 |
Cash | 1,802 | 4,591 | 6,468 | 8,078 |
Basic Shares | 19,559 | 18,298 | 17,511 | 16,668 |
Annual Financials
| Values in thousands | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 |
|---|---|---|---|---|
Revenue | $705 | $464 | $226 | $255 |
Gross Profit | 703 | 459 | 194 | 183 |
EBITDA | -11,880 | -5,676 | -6,388 | -6,516 |
EBIT | -5,753 | -6,534 | -6,619 | |
Net Income | -11,901 | -5,795 | -6,664 | -7,269 |
Net Change In Cash | 705 | 464 | 226 | 255 |
Free Cash Flow | -10,450 | -5,002 | -6,050 | -5,010 |
Cash | 1,802 | 6,499 | 1,352 | 5,813 |
Basic Shares | 17,998 | 12,383 | 6,614 | 5,885 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-11-30 | $0 |
2025-08-31 | -$0.14 |
2025-05-31 | -$0.21 |
2025-02-28 | -$0.15 |
